$IQV

$273.60 -$5.76 (2.06%) Close

$IQV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$IQV Management Team

Mr. Bhavik Patel

President - MedTech and Consumer Health

Age 46

Compensation $3.014M USD

Sex Male

Mr. Kerri Joseph

Senior Vice President - Investor Relations and Treasury

Age -

Compensation -

Sex Male

Mr. Ari Bousbib

Chairman of the Board

Chief Executive Officer

Age 64

Compensation $28.13M USD

Sex Male

Mr. Walter Staub

President - Research and Development Solutions

Age 63

Compensation $8.829M USD

Sex Male

Mr. Eric Sherbet

Executive Vice President

General Counsel

Secretary

Age 61

Compensation $5.501M USD

Sex Male

Mr. Michael Fedock

Chief Financial Officer

Executive Vice President

Age 51

Compensation -

Sex Male

Mr. Alistair Grenfell

President - Commercial Solutions

Age 52

Compensation $9.705M USD

Sex Male

Mr. James Berkshire

Executive Vice President - Global Infrastructure and Operations

Age 52

Compensation -

Sex Male

Mr. Bernd Haas

Executive Vice President - AI and Technology Solutions

Age 50

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Bhavik Patel President - MedTech and Consumer Health	46	$3.014M USD	Male
Mr. Kerri Joseph Senior Vice President - Investor Relations and Treasury	-	-	Male
Mr. Ari Bousbib Chairman of the Board Chief Executive Officer	64	$28.13M USD	Male
Mr. Walter Staub President - Research and Development Solutions	63	$8.829M USD	Male
Mr. Eric Sherbet Executive Vice President General Counsel Secretary	61	$5.501M USD	Male
Mr. Michael Fedock Chief Financial Officer Executive Vice President	51	-	Male
Mr. Alistair Grenfell President - Commercial Solutions	52	$9.705M USD	Male
Mr. James Berkshire Executive Vice President - Global Infrastructure and Operations	52	-	Male
Mr. Bernd Haas Executive Vice President - AI and Technology Solutions	50	-	Male

Board of Directors

From the proxy statement filed Feb 27, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

7.3 years

from year joined

CEO also chairs the board

Yes

Ari Bousbib

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Ari Bousbib Board chair, CEO	64	2016 10 years	Not independent	None stated	The Home Depot, Inc.	Paid as CEO
Carol J. Burt	68	2019 7 years	Independent	LDC Committee · Chair	Resmed Inc.	$385,508
John G. Danhakl	69	2016 10 years	Independent	LDC Committee	Life Time Group Holdings, Inc.	$363,008
James A. Fasano	56	2016 10 years	Independent	Audit Committee · Chair	None stated	$390,508
Colleen A. Goggins	71	2017 9 years	Independent	Audit	Bayer AG	$383,008
William G. Kaelin Jr.	68	2025 1 year	Independent	None stated	Eli Lilly and Company	$28,125
John M. Leonard Lead independent director	68	2015 11 years	Independent	Audit Committee	Intellia Therapeutics, Inc.	$418,008
Leslie Wims Morris	55	2022 4 years	Independent	None stated	None stated	$353,008
Sheila A. Stamps	68	2022 4 years	Independent	Audit Committee	MFA Financial, Inc.	$358,008

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Feb 27, 2026

BlackRock, Inc.

beneficially owns approximately 8.9% of IQVIA's common stock

$668,800

2025

Agreement for a subsidiary of IQVIA to license certain IQVIA information assets to BlackRock, Inc.

With a subsidiary of IQVIA Open in proxy

Comments

Company Executives

$IQV Management Team

Mr. Bhavik Patel

Mr. Kerri Joseph

Mr. Ari Bousbib

Mr. Walter Staub

Mr. Eric Sherbet

Mr. Michael Fedock

Mr. Alistair Grenfell

Mr. James Berkshire

Mr. Bernd Haas

Board of Directors

Related-party transactions